Parkinson's Disease Trial, Not Yet Recruiting
voxsanity.com.au · Eligibility summary from public government registries · 18 August 2026 · not medical advice
Who may and may not be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who may be able to join
- People aged 18 years or older.
- People who have been diagnosed with Parkinson's disease according to a specific set of international diagnostic guidelines called the MDS criteria.
- People whose Parkinson's disease has been rated as stage 1.5 to 3 on a scale called the Hoehn and Yahr scale, which measures how far the condition has progressed (confirm with trial site).
- People who have been seen by a neurologist for at least one month.
- People who have access to a smartphone, computer, or tablet with internet or mobile data — either their own or through a caregiver.
- People who live in France and are enrolled in the French social security system.
Who may not be able to join
Each point below is a reason the trial team may not be able to accept someone. It is not a list of requirements to meet.
- People who are under a legal protection measure such as guardianship, curatorship, or safeguard of justice, or any other official measure that limits their rights and freedoms.
- People who have dementia, mental health conditions, cognitive difficulties, or psychiatric conditions that could affect their ability to give informed consent or follow the study requirements.
- People who are considered unable to manage independently by the study investigator and who do not have a caregiver to assist them.
- People who are already taking part in another interventional research study, unless that study is the "PRECISE-PD" cohort within the NS-PARK network.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Adeline GIANINA, Medipole Hopital Mutualiste
Phone: +33241682940
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Clinical effectiveness of telemonitoring on symptom progression in PD patients assessed by Movement Disorder Society- Unified Parkinson's Disease Rating scale (MDS-UPDRS)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 6 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.